The RANKL/RANK pathway is known for its crucial role in paracrine signaling between stem and differentiated cells in breast cancer, where RANKL, released from PR-positive cells upon P4 stimulation, binds to its receptor on PR-negative progenitor cells and stimulates tumorigenesis through expanding the progenitor cell population [35]. This evidence concerns the gene TNFSF11 and breast cancer.